These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 166804)

  • 1. A pharmacological model of the pathophysioloyg of schizophrenia.
    Klawans HL; Westheimer R; Goetz CC
    Dis Nerv Syst; 1975 May; 36(5):267-75. PubMed ID: 166804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings?
    McDermott E; de Silva P
    Med Hypotheses; 2005; 65(6):1076-81. PubMed ID: 16125330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of scientific models on clinical psychopharmacology: an internist's view.
    Hollister LE
    Semin Psychiatry; 1972 Aug; 4(3):265-9. PubMed ID: 4374762
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions.
    Yarlagadda A
    Med Hypotheses; 2002 Feb; 58(2):182-6. PubMed ID: 11812200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
    Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs].
    Hashimoto K; Iyo M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Feb; 22(1):3-13. PubMed ID: 11917507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical psychopharmacology: the example of clozapine (Leponex)].
    Péré JJ
    Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
    Pietraszek M
    Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia.
    Wang XJ
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S80-7. PubMed ID: 16508903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamatergic neurotransmission in schizophrenics].
    Bleich S; Bleich K; Wiltfang J; Maler JM; Kornhuber J
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S56-61. PubMed ID: 11533851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.